Found 12 matching trials
Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir PHASE2 The objective of this study is to discover a new approach in which human im...
Show More Location
University of California San Francisco
Learn More & Join Trial
Addition of Raltegravir to Established Antiretroviral Suppressive Therapy PHASE4 This study will examine whether intensification with raltegravir of a suppr...
Show More Location
Infectious Diseases Research Unit, University of Miami Miller School of Medicine
Learn More & Join Trial
Clinical Trial to Evaluate the Effect of Raltegravir Intensification (1.200 mg QD) on the Gut Microbiota of Chronically HIV-1 Infected Subject Over Time: THE RAGTIME STUDY PHASE3 The project presented here will be the first prospective, randomized evalua...
Show More Location
Germans Trias i Pujol Hospital
Learn More & Join Trial
Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut NA The "PLUS" study is a pilot study to measure the effect of therapy intensif...
Show More Location
San Francisco General Hospital
Learn More & Join Trial
Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load PHASE3 Switching from enfuvirtide to raltegravir in the treatment of HIV-infected ...
Show More Location
Service des maladies infectieuses et tropicales Hopital Saint Louis
Learn More & Join Trial
Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4+ T Cell Response PHASE4 A research study to measure the effect on CD4 counts of adding to current a...
Show More Location
Multiple Locations
Learn More & Join Trial
Pilot Study of Adding Raltegravir (MK-0518) to Antiretroviral Therapy in Patients With Low Level Viremia NA The medicines used to treat HIV can suppress but cannot kill all the virus ...
Show More Location
University of Pittsburgh
Learn More & Join Trial
Pilot Opened Trial in HIV-infected Patients Including an Investigational Marketed Product PHASE4 This study aims to provide new knowledge about the pathogenesis of HIV infe...
Show More Location
H.U. Germans Trias i Pujol
Learn More & Join Trial
A Study of the Neurological Effects of Adding Raltegravir to HAART Regimen in Patients With HIV PHASE4 HIV related cognitive impairment still occurs despite highly active antiret...
Show More Location
St. Vincent's Hospital
Learn More & Join Trial
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load PHASE2 Raltegravir (MK-0518) is an HIV-1 integrase inhibitor with potent in vitro ...
Show More Location
Alabama Therapeutics CRS
Learn More & Join Trial